averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HNF4G | hg19_v2_chr8_+_76452097_76452126 | -0.23 | 6.1e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_6309963 Show fit | 17.57 |
ENST00000382515.2
|
CD9 molecule |
|
chr2_+_201170770 Show fit | 17.42 |
ENST00000409988.3
ENST00000409385.1 |
spermatogenesis associated, serine-rich 2-like |
|
chr2_+_201170596 Show fit | 17.29 |
ENST00000439084.1
ENST00000409718.1 |
spermatogenesis associated, serine-rich 2-like |
|
chr1_-_24126892 Show fit | 17.03 |
ENST00000374497.3
ENST00000425913.1 |
UDP-galactose-4-epimerase |
|
chr8_-_145641864 Show fit | 16.45 |
ENST00000276833.5
|
solute carrier family 39 (zinc transporter), member 4 |
|
chr1_-_211752073 Show fit | 15.33 |
ENST00000367001.4
|
solute carrier family 30 (zinc transporter), member 1 |
|
chr8_-_145642267 Show fit | 14.81 |
ENST00000301305.3
|
solute carrier family 39 (zinc transporter), member 4 |
|
chr11_+_32112431 Show fit | 14.55 |
ENST00000054950.3
|
reticulocalbin 1, EF-hand calcium binding domain |
|
chr22_+_38071615 Show fit | 14.45 |
ENST00000215909.5
|
lectin, galactoside-binding, soluble, 1 |
|
chr16_+_29690358 Show fit | 14.10 |
ENST00000395384.4
ENST00000562473.1 |
quinolinate phosphoribosyltransferase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.3 | 51.3 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
4.7 | 46.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
2.1 | 36.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 28.1 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
5.3 | 26.4 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.1 | 24.2 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.4 | 22.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
2.8 | 22.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
7.0 | 20.9 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
3.7 | 18.4 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 167.6 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 67.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.6 | 48.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 32.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.6 | 32.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 28.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
3.4 | 27.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 24.5 | GO:0031965 | nuclear membrane(GO:0031965) |
3.0 | 23.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 23.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 52.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
10.4 | 41.7 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.2 | 40.3 | GO:0005178 | integrin binding(GO:0005178) |
0.4 | 34.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.4 | 27.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 26.8 | GO:0005509 | calcium ion binding(GO:0005509) |
4.4 | 22.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 22.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.2 | 21.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
2.6 | 20.9 | GO:0019863 | IgE binding(GO:0019863) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 67.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.7 | 33.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 30.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 27.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 20.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 15.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 14.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 13.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 13.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 12.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 52.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 37.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
1.3 | 34.5 | REACTOME KINESINS | Genes involved in Kinesins |
1.5 | 33.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 32.0 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.9 | 24.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 24.3 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.2 | 23.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.7 | 22.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 21.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |